Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Meridian Clinical Research (Rockville Neurology)
mi
from 43215
Rockville, MD
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research (Rockville Neurology)
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consortium
1756
mi
from 43215
Las Vegas, NV
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consortium
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
356
mi
from 43215
Rochester, NY
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Rapid Medical Research, Inc.
130
mi
from 43215
Cleveland, OH
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Rapid Medical Research, Inc.
130
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
523
mi
from 43215
Mount Pleasant, SC
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
523
mi
from 43215
Mount Pleasant, SC
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Baptist Health Center for Clinical Research
625
mi
from 43215
Little Rock, AR
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Baptist Health Center for Clinical Research
625
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
CI Trials
1929
mi
from 43215
Riverside, CA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
CI Trials
1929
mi
from 43215
Riverside, CA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Neurological Research Institute
1985
mi
from 43215
Santa Monica, CA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Neurological Research Institute
1985
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Palm Beach Research
931
mi
from 43215
West Palm Beach, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Palm Beach Research
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
BTC of New Bedford
642
mi
from 43215
New Bedford, MA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
BTC of New Bedford
642
mi
from 43215
New Bedford, MA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
MedVadis Research
636
mi
from 43215
Watertown, MA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
MedVadis Research
636
mi
from 43215
Watertown, MA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
1759
mi
from 43215
Las Vegas, NV
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
1759
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
356
mi
from 43215
Rochester, NY
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
CTI Clinical Research Center
92
mi
from 43215
Cincinnati, OH
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
CTI Clinical Research Center
92
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Neurology and Sleep Lab, LP
1062
mi
from 43215
Austin, TX
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology and Sleep Lab, LP
1062
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Texas Center for Drug Development, P.A.
991
mi
from 43215
Houston, TX
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Charlottesville Medical Research Inc.
279
mi
from 43215
Charlottesville, VA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Inc.
279
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
New England Institute for Neurology and Headache (NEINH)/Medical Practice
mi
from 43215
Stamford, CT
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
New England Institute for Neurology and Headache (NEINH)/Medical Practice
mi
from 43215
Stamford, CT
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Neurostudies Clinical Research
mi
from 43215
Decatur, GA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Neurostudies Clinical Research
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Precision Clinical Research
965
mi
from 43215
Lauderdale Lakes, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Precision Clinical Research
965
mi
from 43215
Lauderdale Lakes, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solution, Inc
795
mi
from 43215
Orlando, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solution, Inc
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Dallas, LP
905
mi
from 43215
Dallas, TX
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Dallas, LP
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solution, Inc.
673
mi
from 43215
Jacksonville, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solution, Inc.
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
PMG Research of Wilmington
484
mi
from 43215
Wilmington, NC
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of Wilmington
484
mi
from 43215
Wilmington, NC
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
516
mi
from 43215
North Charleston, SC
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
516
mi
from 43215
North Charleston, SC
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solution, Inc
503
mi
from 43215
Memphis, TN
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solution, Inc
503
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
A Pilot Study of Creative Arts Interventions for Neurology Inpatients in the Epilepsy Monitoring Unit and the Headache Service
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
A Pilot Study of Creative Arts Interventions for Neurology Inpatients in the Epilepsy Monitoring Unit and the Headache Service
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Prospective ED Headache Cohort Study
Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center, 111 East 210th Street
482
mi
from 43215
Bronx, NY
Prospective ED Headache Cohort Study
Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center, 111 East 210th Street
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Metoclopramide for Migraine: A Dose Finding Study
Metoclopramide for Acute Migraine: A Dose Finding Study
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Metoclopramide for Migraine: A Dose Finding Study
Metoclopramide for Acute Migraine: A Dose Finding Study
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Mindfulness and Migraine Research Study
Mindfulness and Migraine: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Palo Alto Medical Foundation Research Institute
2099
mi
from 43215
Palo Alto, CA
Mindfulness and Migraine Research Study
Mindfulness and Migraine: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Palo Alto Medical Foundation Research Institute
2099
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
Status: Enrolling
Updated:  12/31/1969
Massachusetts Eye & Ear Infirmary
643
mi
from 43215
Boston, MA
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye & Ear Infirmary
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
410
mi
from 43215
Huntsville, AL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
410
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2083
mi
from 43215
Walnut Creek, CA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2083
mi
from 43215
Walnut Creek, CA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1174
mi
from 43215
Boulder, CO
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1174
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
922
mi
from 43215
Palm Beach Gardens, FL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
922
mi
from 43215
Palm Beach Gardens, FL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
997
mi
from 43215
South Miami, FL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
966
mi
from 43215
Sunrise, FL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
966
mi
from 43215
Sunrise, FL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
441
mi
from 43215
Conyers, GA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
441
mi
from 43215
Conyers, GA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
280
mi
from 43215
Evansville, IN
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
280
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Research Site
633
mi
from 43215
Wellesley Hills, MA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Research Site
633
mi
from 43215
Wellesley Hills, MA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
604
mi
from 43215
Worcester, MA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
164
mi
from 43215
Ann Arbor, MI
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
585
mi
from 43215
Springfield, MO
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
585
mi
from 43215
Springfield, MO
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
513
mi
from 43215
Albany, NY
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
321
mi
from 43215
Greensboro, NC
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
321
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials